Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tenzin Tsomo"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Collaborative innovation between hospitals and biomedical enterprises is crucial for ensuring breakthroughs in their development. This study explores the structural characteristics and examines the main roles of associated key actors of coll
Externí odkaz:
https://doaj.org/article/a7a6d3822923492780e8584cd83c773e
Publikováno v:
GLOBAL JOURNAL FOR RESEARCH ANALYSIS. :169-171
Urinary catheterisation is one of the most commonly performed urological emergency procedures worldwide. A long dwelling urinary catheter could be complicated by catheter obstruction due to encrustation and stone formation. Traditionally open cystoli
Autor:
Neil Bailey, Tori Braun, Megumi Bailey, Tenzin Tsomo, Jennie Szeto, Sandra Benitez Kruidenier, Vanessa Dunleavy, Joanna Fesler, Gayle Funk, Sonia Glennie, Judson Hall, Julia Parker, Daniel Egan, Raya Mawad, Carol A Dean, Suzan Sullivan, Chia Lu, Heidi Hohmann, Jordan Briggs, Krish Patel
Publikováno v:
Blood. 140:3765-3766
Autor:
Megumi Bailey, Tenzin Tsomo, Neil Bailey, Tori Braun, Chiachun Lu, Carol Dean, Shannon Williams, Gayle Funk, Joanna Fesler, Sonia Glennie, Judson Hall, Vanessa Dunleavy, Daniel Egan, Raya Mawad, Livia Hegerova, Krish Patel, John M. Pagel, William Bensinger
Publikováno v:
Transplantation and Cellular Therapy. 28:S239-S240
Autor:
Tori Braun, Vanessa Dunleavy, Gayle Funk, Megumi Bailey, Neil Bailey, Krish Patel, Livia Hegerova, Tenzin Tsomo, Heidi Hohmann, Judson Hall, John M. Pagel, Sonia Glennie, Jordan Briggs, William I. Bensinger, Jennie Szeto, Daniel J. Egan, Raya Mawad, Joanna Fesler, Joshua Mark
Publikováno v:
Blood. 138:4554-4554
Background: Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) often have a poor prognosis despite therapies using second-line chemoimmunotherapy (CIT). Achievement of complete response (CR) with second-line therapy is asso
Autor:
Neil Bailey, Tenzin Tsomo, Livia Hegerova, David Kane, Sonia Glennie, William I. Bensinger, Raya Mawad, Ami Batchelder, Joey Ferry, John M. Pagel, Heather Holdread, Jennie Szeto, Daniel J. Egan, Krish Patel, Judson Hall, Joanna Fesler, Megumi Bailey
Publikováno v:
Blood. 136:34-34
Background: Patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) often have a poor prognosis despite therapies using second-line chemoimmunotherapy. Achievement of CR with second-line therapy is associated with improved long-
Autor:
Kimberly Kelsey, Dolma Tso, Sara Shea, Mary Uy, Fasha Ruys-solorzano, Brianna-Kirsten Tan, Crystal Hunter, Sasha Riley, Heather Holland, Tenzin Tsomo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a267cc05ef8b5fe97c5c2a98b9fb255
https://doi.org/10.33015/dominican.edu/2016.nurs.rp.01
https://doi.org/10.33015/dominican.edu/2016.nurs.rp.01
Autor:
Jennie Szeto, Raya Mawad, Tenzin Tsomo, Ngan Trinh, Paul Wisniewski, Livia Hegerova, John M. Pagel, Michael Milder, Clarisse M. Zayas, William I. Bensinger, Krish Patel, Neil Bailey
Publikováno v:
Blood. 132:1715-1715
Introduction: Patients with Diffuse large B-cell lymphoma (DLBCL) may experience excellent long-term outcomes after initial anthracycline containing therapy. However, patients with relapsed or refractory (R/R) DLBCL often have poor outcomes. Select R